Stocktoria

Cordyceps Sunshine Biotech Holdings Co., Ltd. RAJAF

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2023-10-09

Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $1.2M at a -12.4% net margin.

$9.18 high · $9.18 low · daily closes (~2y) · hover for date & price
23/100
Stocktoria Quality Score · grade D
4/9
Piotroski F — financial health
-6.82
Altman Z″ — distress risk · distress
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
3 7 5 4 2022202320242025
Altman Z″
-9.84 -5.21 -7.06 -6.82 2022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$9.18 as of 2026-08-01 · +0% 1y
Market cap USD$578M
Net margin 5y avg-270.4%
Beta-61.62
Employees15
Revenue trend · last 5y · up

How it ranks in Manufacturing · percentile among 1995 companies

Piotroski Fstronger than 45%
Net marginstronger than 39%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets-0.901
Retained earnings / assets-0.183
EBIT / assets-0.03
Equity / liabilities-0.103

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
RAJAFCordyceps Sunshine Biotech Holdings Co., Ltd.4/9-6.82
NPHCNUTRA PHARMA CORP3/9
PLSHPANACEA LIFE SCIENCES HOLDINGS, INC.4/9-13.95
NTRRNEUTRA CORP.4/9
FTLFFITLIFE BRANDS, INC.3/91.9951.6-75.3%
BONBon Natural Life Ltd4/94.25-21.7%
CHUCCharlie's Holdings, Inc.3/9-1.3513.2

All Manufacturing companies →

About Cordyceps Sunshine Biotech Holdings Co., Ltd.

Cordyceps Sunshine Biotech Holdings Co., Ltd. cultivates and sells Chinese rare medicinal herb, taiwanofungus raw material, and finished products in China. It offers Taiwanofungus Oral pill, a pill form dietary supplement; Taiwanofungus Double A Oral shot; TAIWANOFUNGUS x SALVIA MILTIORRHIZA ORAL Shot; and Collagen Max Drink, a liquid form dietary supplement; and Barbie Coco, a chocolate product. The company also exports its products to Hong Kong and Mainland China. It offers its products through online e-commerce platforms, physical chain stores, collaboration with major retail brands, and partnerships with retail channels. The company was incorporated in 2020 and is based in Taipei, Taiwan.

FAQ

Is RAJAF financially healthy?

Cordyceps Sunshine Biotech Holdings Co., Ltd.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does RAJAF pay a dividend?

No, Cordyceps Sunshine Biotech Holdings Co., Ltd. does not currently pay a dividend.

How profitable is RAJAF?

In FY2025, Cordyceps Sunshine Biotech Holdings Co., Ltd. had a net margin of -12.4%.

Is RAJAF a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Cordyceps Sunshine Biotech Holdings Co., Ltd.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.